[1] Timor-Tritsch I E, Monteagudo A, Calì G, et al. Cesarean scar pregnancy:Diagnosis and pathogenesis[J]. Obstetrics and Gynecology Clinics of North America, 2019, 46(4):797-811. [2] Timor-Tritsch I E, Monteagudo A, Calì G, et al. Cesarean scar pregnancy:Patient counseling and management[J]. Obstetrics and Gynecology Clinics of North America, 2019, 46(4):813-828. [3] Jiang F Y, Nong W Z, Su H Q, et al. Intrauterine ectopic pregnancy-ultrasound typing and treatment[J]. Ginekologia Polska, 2020, 91(3):111-116. [4] 程岑,宋亭,刘祎,等. MRI在妊娠物残留的诊断及鉴别诊断中的价值[J].临床放射学杂志, 2020, 39(3):528-533. [5] Hu J L, Zhang J M, Chan Y, et al. A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes[J]. Journal of Obstetrics and Gynaecology Research, 2019, 45(10):1980-1988. [6] 毕美娥,邵龙,陶晓静.甲胎蛋白、hCG检测联合多普勒彩超评估凶险性前置胎盘合并胎盘植入价值[J].中国计划生育学杂志, 2019, 27(4):501-503, 507. [7] 李春玲,张震宇,刘崇东.超声与磁共振诊断剖宫产瘢痕妊娠一致性对比研究[J].中国实用妇科与产科杂志, 2019, 35(9):1031-1034. [8] Yang D X, Zhang Z, Kang Z L, et al. Application and comparative analysis of 3.0T MRI and ultrasound in diagnosing CSP after caesarean section[J]. American Journal of Translational Research, 2021, 13(4):3806-3810. [9] Mor A, Gardezi M, Jubanyik K, et al. Miscarriage determination in first trimester based on alpha-fetoprotein extracted from sanitary pads[J]. Fertility and Sterility, 2021, 116(2):462-469. [10] Wang X, Chen Y, Kuang H L, et al. Associations between maternal AFP and β-HCG and preterm birth[J]. American Journal of Perinatology, 2019, 36(14):1459-1463. [11] Borovkov V A, Igitova M B, Korenovskiy Y V, et al. Prognostic significance of specific proteins of pregnancy in women with a uterine scar and placenta accreta[J]. Klinicheskaia Laboratornaia Diagnostika, 2020, 65(6):353-357. [12] Zaghal A A, Hussain H K, Berjawi G A. MRI evaluation of the placenta from normal variants to abnormalities of implantation and malignancies[J]. Journal of Magnetic Resonance Imaging, 2019, 50(6):1702-1717. [13] Chen X, Shan R Q, Song Q X, et al. Placenta percreta evaluated by MRI:Correlation with maternal morbidity[J]. Archives of Gynecology and Obstetrics, 2020, 301(3):851-857. [14] Guo S N, Wang H T, Yu X Y, et al. The diagnostic value of 3.0T MRI in cesarean scar pregnancy[J]. American Journal of Translational Research, 2021, 13(6):6229-6235. [15] Do Q N, Lewis M A, Xi Y, et al. MRI of the placenta accreta spectrum (PAS) disorder:Radiomics analysis correlates with surgical and pathological outcome[J]. Journal of Magnetic Resonance Imaging, 2020, 51(3):936-946. [16] Clark H R, Ng T W, Khan A, et al. Placenta accreta spectrum:Correlation of MRI parameters with pathologic and surgical outcomes of high-risk pregnancies[J]. American Journal of Roentgenology, 2020, 214(6):1417-1423. [17] Berezowsky A, Pardo J, Ben-Zion M, et al. Second trimester biochemical markers as possible predictors of pathological placentation:A retrospective case-control study[J]. Fetal Diagnosis and Therapy, 2019, 46(3):187-192. [18] 李萍,翟俊英,李宛玲.血清HCG、AFP水平联合MRI在前置胎盘植入及其分类诊断中的应用[J].中国CT和MRI杂志, 2019, 17(2):84-86, 117. |